CD4 and Opportunistic infection: The World Health Organization (WHO) recommends screening, treatment and prophylaxis for major opportunistic infections, rapid ART initiation, and enhanced ART adherence support for adults and adolescents, and children ≥5 years old, presenting with a CD4 cell count <200 cells /μL or a WHO clinical stage 3 or 4 event [32].